In this CME Outfitters AI-powered precision learning activity, expert faculty will help clinicians translate the latest evidence into meaningful improvements in patient care. Learners will explore the immunometabolic mechanisms through which visceral and mesenteric adipose tissue drive IBD disease activity, influence treatment response, and increase surgical risk in people living with IBD and obesity. Through interactive modules, learners will strengthen their ability to systematically assess and characterize adiposity using validated approaches during routine gastroenterology visits, identify individuals at highest risk based on adiposity distribution, and apply these insights to real-world clinical decision-making. Faculty will demonstrate how to build individualized, patient-centered treatment plans that integrate weight management strategies and the safe, evidence-based use of GLP-1 receptor agonists, empowering learners to deliver more precise, personalized care.
This event is neither sponsored by nor endorsed by ACG.